Phaarmasia Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 306122, "name": "Phaarmasia", "stock_name": "Phaarmasia", "full_name": "Phaarmasia Ltd", "name_url": "stocks-analysis/phaarmasia", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "97.83", "chg": 8.89, "chgp": "10.0%", "dir": 1, "prev_price": "88.94", "mcapval": "61.00 Cr", "mcap": "Micro Cap", "scripcode": 523620, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE486I01016", "curr_date": "Apr 10", "curr_time": "", "bse_nse_vol": "748 ", "exc_status": "Active", "traded_date": "Apr 10, 2026", "traded_date_str": "2026 04 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/phaarmasia-306122-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3930154", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PhaarmasiaLtd_mojoScore_3930154.png", "date": "2026-04-02 10:10:29", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3893204", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PhaarmasiaLtd_mojoScore_3893204.png", "date": "2026-03-16 10:10:31", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 March 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3873051", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PhaarmasiaLtd_mojoScore_3873051.png", "date": "2026-03-05 10:10:53", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3849255", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_mojoScore_3849255.png", "date": "2026-02-21 10:10:31", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Phaarmasia Ltd Gains 11.55%: Key Valuation and Technical Upgrades Drive Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-gains-1155-key-valuation-and-technical-upgrades-drive-rally-3840701", "imagepath": "", "date": "2026-02-15 09:00:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>09 Feb:</strong> Stock opens at ₹108.81 following upgrade to Hold</p>\n <p><strong>10 Feb:</strong> Valuation shifts signal renewed price attractiveness</p>\n <p><strong>12 Feb:</strong> Minor correction amid broader market weakness</p>\n <p><strong>13 Feb:</strong> Week closes at ₹115.60, up 11.55% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹103.63</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹115.60</div><div cl..." }, { "title": "Phaarmasia Ltd Upgraded to Hold as Valuation and Technicals Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-upgraded-to-hold-as-valuation-and-technicals-improve-3829845", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_mojoScore_3829845.png", "date": "2026-02-10 08:05:07", "description": "Phaarmasia Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across technical indicators and valuation metrics. The company’s recent financial performance, coupled with a bullish technical outlook and attractive valuation compared to peers, has prompted this reassessment by analysts as of 09 Feb 2026." }, { "title": "Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-valuation-shifts-signal-renewed-price-attractiveness-3829521", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_valuationdot_3829521.png", "date": "2026-02-10 08:00:42", "description": "Phaarmasia Ltd has witnessed a significant re-rating in its valuation parameters, transitioning from a previously expensive profile to one now deemed attractive by market standards. This shift is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector." }, { "title": "Phaarmasia Ltd Gains 4.68%: Downgrade and Q2 Results Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-gains-468-downgrade-and-q2-results-shape-the-week-3827094", "imagepath": "", "date": "2026-02-08 10:00:13", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens at Rs.99.00, Sensex down 1.03%</p>\n <p><strong>4 Feb:</strong> Stock drops 5.00% to Rs.94.05 following downgrade</p>\n <p><strong>5 Feb:</strong> MarketsMOJO downgrades Phaarmasia Ltd to Sell</p>\n <p><strong>6 Feb:</strong> Q2 FY26 results reveal sharp profit growth; stock rebounds to Rs.103.63</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.99.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.103...." }, { "title": "Are Phaarmasia Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-phaarmasia-ltd-latest-results-good-or-bad-3826807", "imagepath": "", "date": "2026-02-07 19:17:51", "description": "Phaarmasia Ltd's latest financial results present a mixed picture, highlighting both significant operational improvements in the most recent quarter and underlying structural challenges. In Q2 FY26, the company reported a net profit of ₹1.74 crores, a substantial increase compared to the previous quarter, alongside a remarkable revenue growth of 179.09% year-on-year, reaching ₹16.55 crores. This quarter also marked an operating margin of 9.73%, a notable recovery from a loss in the same quarter of the previous year.\n\nHowever, these positive results must be contextualized against the company's overall performance. For the fiscal year ending March 2025, Phaarmasia experienced a decline in net sales to ₹24.00 crores, down 20% from the previous year, and reported an operating loss of ₹2.00 crores. The recent quarterly spike in performance appears to be an anomaly rather than a sustained trend, as the company ha..." } ], "total": 718, "sid": "306122", "stock_news_url": "https://www.marketsmojo.com/news/phaarmasia-306122" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "27-Mar-2026", "details": "Closure of Trading window under Reg 30 of SEBI (LODR) Reg 2015 for the Quarter and Financial year ended 31st March 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "09-Feb-2026", "details": "Newspaper Advertisement of unaudited Financial results for the Quarter ended 31st December 2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 06Th February 2026 At 05.00 PM", "datetime": "06-Feb-2026", "details": "Submission of Outcome of Board Meeting held on Friday 06th February 2026 at 05.00 PM for the Quarter ended 31 December 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

09 Feb: Stock opens at ₹108.81 following upgrade to Hold

10 Feb: Valuation shifts signal renewed price attractiveness

12 Feb: Minor correction amid broader market weakness

13 Feb: Week closes at ₹115.60, up 11.55% for the week

Read full news article

Phaarmasia Ltd Upgraded to Hold as Valuation and Technicals Improve

2026-02-10 08:05:07

Phaarmasia Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across technical indicators and valuation metrics. The company’s recent financial performance, coupled with a bullish technical outlook and attractive valuation compared to peers, has prompted this reassessment by analysts as of 09 Feb 2026.

Read full news article

Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-02-10 08:00:42

Phaarmasia Ltd has witnessed a significant re-rating in its valuation parameters, transitioning from a previously expensive profile to one now deemed attractive by market standards. This shift is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Phaarmasia Ltd Gains 4.68%: Downgrade and Q2 Results Shape the Week

2026-02-08 10:00:13

Key Events This Week

2 Feb: Stock opens at Rs.99.00, Sensex down 1.03%

4 Feb: Stock drops 5.00% to Rs.94.05 following downgrade

5 Feb: MarketsMOJO downgrades Phaarmasia Ltd to Sell

6 Feb: Q2 FY26 results reveal sharp profit growth; stock rebounds to Rs.103.63

Read full news article

Are Phaarmasia Ltd latest results good or bad?

2026-02-07 19:17:51

Phaarmasia Ltd's latest financial results present a mixed picture, highlighting both significant operational improvements in the most recent quarter and underlying structural challenges. In Q2 FY26, the company reported a net profit of ₹1.74 crores, a substantial increase compared to the previous quarter, alongside a remarkable revenue growth of 179.09% year-on-year, reaching ₹16.55 crores. This quarter also marked an operating margin of 9.73%, a notable recovery from a loss in the same quarter of the previous year. However, these positive results must be contextualized against the company's overall performance. For the fiscal year ending March 2025, Phaarmasia experienced a decline in net sales to ₹24.00 crores, down 20% from the previous year, and reported an operating loss of ₹2.00 crores. The recent quarterly spike in performance appears to be an anomaly rather than a sustained trend, as the company ha...

Read full news article

View All News